Featured Research

from universities, journals, and other organizations

Medication Helps Alcoholics Control Drinking

Date:
March 5, 2005
Source:
Center For The Advancement Of Health
Summary:
A little-known drug called naltrexone provides a “meaningful benefit” in helping alcoholics moderate their drinking, according to the latest review of evidence from 29 studies on four continents.

A little-known drug called naltrexone provides a “meaningful benefit” in helping alcoholics moderate their drinking, according to the latest review of evidence from 29 studies on four continents.

Related Articles


The findings, along with the recent FDA approval of a similar drug called acamprosate, open the door to new treatment options for drinkers who aren’t yet ready to face total abstinence.

Naltrexone, which is not addictive, “should be accepted as a short-term treatment for alcoholism,” say authors Dr. Manit Srisurapanont and Dr. Ngamwong Jarusuraisin of Thailand’s Chiang Mai University. Almost all of the studies tested naltrexone, or NTX, in combination with psychosocial treatments such as counseling or self-help groups, and the authors recommend using this approach in everyday practice.

The review’s conclusions are based on “high-quality evidence” that naltrexone reduces by 36 percent the risk of an alcoholic relapsing to heavy drinking in the first three months of recovery. “Short-term treatment of NTX for alcoholism gives a meaningful benefit in preventing a relapse,” the review said, citing an 18 percent lower likelihood that patients will abandon their treatment program.

The review appears in the most recent issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

Dr. Joseph Volpicelli, of the University of Pennsylvania School of Medicine, has been conducting research on naltrexone use for alcohol dependence since the early 1980s. Naltrexone blocks the brain’s receptors for natural painkillers, known as opioids, which normally create the feeling of wellbeing associated with drinking.

He explains that the benefits of naltrexone lie not so much in preventing a patient from having one drink, but rather in breaking the cycle where one drink leads to many more. “Naltrexone helps people have more control over the use of alcohol. For me, that’s the fundamental issue of what addiction is: impaired control.”

However, this approach requires a substantial change from the abstinence-only philosophy that goes back at least as far as Prohibition. Naltrexone is most effective, says Volpicelli, in a treatment program “designed to support the notion that while one drink is not great, what you really want to stop is excessive drinking.”

While few professionals advise people with alcoholism to abandon the ultimate goal of total abstinence, Volpicelli argues that about 20 million Americans suffer from alcohol abuse disorders, yet only about 2 million are in any kind of treatment program. “We should be flexible enough to get at that 90 percent of people who aren’t in treatment,” he says.

The U.S. Substance Abuse and Mental Health Services Administration agrees in its naltrexone treatment protocol, saying, “Abstinence should be a desired goal for the patient; however, reductions in drinking may be an acceptable intermediate outcome … because there are many other areas of a patient’s life that can improve, such as job performance, social relationships, and general physical health.”

Although naltrexone (ReVia) has been available for more than 10 years, Volpicelli says it has been poorly marketed, and most patients and primary care doctors remain unaware of its potential. That may change now that the manufacturer of acamprosate (Campral) has embarked on a campaign to promote pharmacological treatment of alcohol addiction.

Review author Srisurapanont notes that the availability of both medicines now gives patients an alternative if one is not effective for them. And, he adds, the possible benefits of using the medications in combination should be studied. The review also notes that other areas ripe for future study include the possible benefit of continuing naltrexone treatment beyond the first three months of recovery and strategies to further increase treatment completion.

Volpicelli believes psychiatry is on the brink of recognizing a new standard of care for alcohol abuse disorders: allowing patients to choose from a variety of treatments, which may or many not focus on total abstinence. It is, he believes, a time of great hope. To those who suffer with alcoholism, he says, “Be aware of all the options available and find the best one for you. See someone, stay in treatment, and over time you’re going to get better.”

###

1. Srisurapanont M, Jarusuraisin N. Opioid Antagonists for Alcohol Dependence (Review). The Cochrane Database of Systematic Reviews 2005, Issue 1


Story Source:

The above story is based on materials provided by Center For The Advancement Of Health. Note: Materials may be edited for content and length.


Cite This Page:

Center For The Advancement Of Health. "Medication Helps Alcoholics Control Drinking." ScienceDaily. ScienceDaily, 5 March 2005. <www.sciencedaily.com/releases/2005/02/050223143048.htm>.
Center For The Advancement Of Health. (2005, March 5). Medication Helps Alcoholics Control Drinking. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2005/02/050223143048.htm
Center For The Advancement Of Health. "Medication Helps Alcoholics Control Drinking." ScienceDaily. www.sciencedaily.com/releases/2005/02/050223143048.htm (accessed October 24, 2014).

Share This



More Mind & Brain News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Academic Scandal Shocks UNC

Academic Scandal Shocks UNC

AP (Oct. 23, 2014) A scandal involving bogus classes and inflated grades at the University of North Carolina was bigger than previously reported, a new investigation found. (Oct. 23) Video provided by AP
Powered by NewsLook.com
Working Mother Getaway: Beaches Turks & Caicos

Working Mother Getaway: Beaches Turks & Caicos

Working Mother (Oct. 22, 2014) Feast your eyes on this gorgeous family-friendly resort. Video provided by Working Mother
Powered by NewsLook.com
What Your Favorite Color Says About You

What Your Favorite Color Says About You

Buzz60 (Oct. 22, 2014) We all have one color we love to wear, and believe it or not, your color preference may reveal some of your character traits. In celebration of National Color Day, Krystin Goodwin (@kyrstingoodwin) highlights what your favorite colors may say about you. Video provided by Buzz60
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins